Liver Transplantation

New England Journal of Medicine

Volumn 321, Issue 15, 1989, Pages 1014-1022

  Starzl, Thomas E ^a   Demetris, Anthony J ^a   Thiel, David Van ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; METABOLISM; NONHUMAN; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; REVIEW;

HUMAN; LIVER TRANSPLANTATION; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024968069     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198910123211505     Document Type: Review

References (119)

1. National Institutes of Health Consensus Development Conference Statement: liver transplantation — June 20–23, 1983. Hepatology 1983: Suppl: 107S–110S.
2. Starzl TE, Iwatsuki S, Van Thiel DH, et al. Evolution of liver transplantation. Hepatology 1982; 2: 614–36.
3. Darby JM, Stein K, Grenvik A, Stuart SA. Approach to management of the heart beating 'brain dead' organ donor. JAMA 1989; 261: 2222–8.
4. Popper H. Coming of age. Hepatology 1985; 5: 1224–6.
5. Makowka L, Gordon RD, Todo S, et al. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 1987; 19: 2378–82.
6. van Woerden WF, Prium J, Knol E, et al. Donor data of liver grafts with primary non-function (PNF): a preliminary analysis on behalf of the European Liver Registry (ELR). Transplant Proc 1989; 21: 2383–4.
7. Jamieson NV, Sundberg R, Lindell S, et al. Successful 24- to 30-hour preservation of the canine liver: a preliminary report. Transplant Proc 1988; 20: Suppl 1: 945–7.
8. Kalayoglu M, Sollinger HW, Stratta RJ, et al. Extended preservation of the liver for clinical transplantation. Lancet 1988; 1: 617–9.
9. Todo S, Nery J, Yanaga K, Podesta L, Gordon RD, Starzl TE. Extended preservation of human liver grafts with UW solution. JAMA 1989; 261: 711–4.
10. Iwatsuki S, Starzl TE, Todo S, et al. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc 1988; 20: Suppl 1: 498–504.
11. Busuttil RW, Colonna JO II, Hiatt JR, et al. The first 100 liver transplants at UCLA. Ann Surg 1987; 206: 387–402.
12. Samuel D, Benhamou JP, Bismuth H, Gugenheim J, Ciardullo M, Saliba F. Criteria of selection for liver transplantation. Transplant Proc 1987; 19: 2383–6.
13. Friend PJ, Lim S, Smith M, et al. Liver transplantation in the Cambridge/King's College Hospital series — the first 400 patients. Transplant Proc 1989; 21: 2397–8.
14. Wall WJ. Liver transplantation: current concepts. Can Med Assoc J 1988; 139: 21–8.
15. Pichlmayr R, Ringe B, Lauchart W, Wonigeit K. Liver transplantation. Transplant Proc 1987; 19: 103–12.
16. Adler M, Gavaler JS, Duquesnoy R, et al. Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg 1988; 208: 196–202.
17. Starzl TE, Van Thiel D, Tzakis AG, et al. Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988; 260: 2542–4.
18. Dummer JS, Erb S, Breinig MK, et al. Infection with human immunodeficiency virus in the Pittsburgh transplant population: a study of 583 donors and 1043 recipients, 1981–1986. Transplantation 1989; 47: 134–40.
19. Rubin RH, Jenkins RL, Shaw BW Jr, et al. The acquired immunodeficiency syndrome and transplantation. Transplantation 1987; 44: 1–4.
20. Starzl TE, Todo S, Gordon R, et al. Liver transplantation in older patients. N Engl J Med 1987; 316: 484–5.
21. Esquivel CO, Koneru B, Karrer F, et al. Liver transplantation before 1 year of age. J Pediatr 1987; 110: 545–8.
22. Shiel AGR, Thompson JF, Stevens MS, Eyers AA, Graham JC, Bookallil MJ. Mesoportal graft for thrombosed portal vein in liver transplantation. Clin Transplant 1987; 1: 18–20.
23. Tzakis A, Todo S, Steiber A, Starzl TE. Venous jump grafts for liver transplantation in patients with portal vein thrombosis. Transplantation 1989; 48: 530.
24. Lerut J, Tzakis AG, Bron K, et al. Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg 1987; 205: 404–14.
25. Iwatsuki S, Starzl TE, Todo S, et al. Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988; 104: 697–705.
26. Hood JM, Koep LJ, Peters RL, et al. Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med 1980; 302: 272–5.
27. Starzl TE. Surgery for metabolic liver disease. In: McDermott WV Jr, ed. Surgery of the liver. Oxford: Blackwell Scientific, 1989:127–36.
28. Groth CG, Dubois RS, Corman J, et al. Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc 1973; 5: 829–33.
29. Starzl TE, Zitelli BJ, Shaw BW Jr, et al. Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr 1985; 106: 604–6.
30. Malatack JJ, Finegold DN, Iwatsuki S, et al. Liver transplantation for type I glycogen storage disease. Lancet 1983; 1: 1073–5.
31. Mieles L, Orenstein D, Teperman L, Podesta L, Koneru B, Starzl TE. Liver transplantation in cystic fibrosis. Lancet 1989; 1: 1073.
32. Daloze P, Delvin EE, Glorieux FH, Corman JL, Bettez P, Toussi T. Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet 1977; 1: 229–39.
33. Gartner JC Jr, Bergman I, Malatack JJ, et al. Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics 1986; 77: 104–6.
34. Samuel D, Boboc B, Bernuau J, Bismuth H, Bernhamou JP. Liver transplantation for protoporphyria: evidence for the predominant role of the erythropoietic tissue in protoporphyrin overproduction. Gastroenterology 1988; 95: 816–9.
35. Polson RJ, Lim CK, Rolles K, Calne RY, Williams R. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation 1988; 46: 386–9.
36. Wolff H, Otto G, Giest H. Liver transplantation in Crigler-Najjar syndrome: a case report. Transplantation 1986; 42: 84.
37. Watts RWE, Calne RY, Rolles K, et al. Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 1987; 2: 474–5.
38. McDonald JC, Landreneau MD, Rohr MS, DeVault GA Jr. Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. N Engl J Med (in press).
39. Casella JF, Lewis JH, Bontempo FA, Zitelli B, Markel H, Starzl TE. Successful treatment of homozygous protein C deficiency by hepatic transplantation. Lancet 1988; 1: 435–8.
40. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984; 311: 1658–64.
41. Lewis JH, Bontempo FA, Spero JA, Ragni MV, Starzl TE. Liver transplantation in a hemophiliac. N Engl J Med 1985; 312: 1189–90.
42. Merion RM, Delius RE, Campbell DA Jr, Turcotte JG. Orthotopic liver transplantation totally corrects factor IX deficiency in hemophilia B. Surgery 1988; 104: 929–31.
43. Dzik WH, Arkin CF, Jenkins RL. Transfer of congenital factor XI deficiency from a donor to a recipient by liver transplantation. N Engl J Med 1987; 316: 1217–8.
44. Parkman R. The application of bone marrow transplantation to the treatment of genetic diseases. Science 1986; 232: 1373–8.
45. Starzl TE, Marchioro TL, Von Kaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659–76.
46. Starzl TE, ed. Experience in hepatic transplantation. Philadelphia: W.B. Saunders, 1969:1–545.
47. Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202: 401–7.
48. Koneru B, Cassavilla A, Bowman J, Iwatsuki S, Starzl TE. Liver transplantation for malignant tumors. Gastroenterol Clin North Am 1988; 17: 177–93.
49. Pichlmayr R, Ringe B, Wittekind C, et al. Liver grafting for malignant tumors. Transplant Proc 1989; 21: 2403–5.
50. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver disease. Vol. 3. New York: Grune & Stratton, 1970:282–98.
51. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definition and causes. Semin Liver Dis 1986; 6: 97–106.
52. Iwatsuki S, Esquivel CO, Gordon RD, et al. Liver transplantation for fulminant hepatic failure. Semin Liver Dis 1985; 5: 325–8.
53. Bismuth H, Samuel D, Gugenheim J, et al. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987; 107: 337–41.
54. O'Grady JG, Alexander GJM, Thick M, Potter D, Calne RY, Williams R. Outcome of orthotopic liver transplantation in the aetiological and clinical varients of acute liver failure. Q J Med 1988; 69: 817–24.
55. Ringe B, Pichlmayr R, Lauchart W, Muller R. Indications and results of liver transplantation in acute hepatic failure. Transplant Proc 1986; 18: Suppl 3: 86–8.
56. Christensen E, Bremmelgaard A, Bahnsen M, Andreasen PB, Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 1984; 19: 90–6.
57. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439–45.
58. Starzl TE, Gordon RD, Tzakis A, et al. Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc 1988; 20: 131–8.
59. Ghent CN. The liver transplant candidate: assessment and follow-up. In: Maddrey WC, ed. Transplantation of the liver. New York: Elsevier Science, 1988:59–86.
60. Shaw BW Jr, Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TE. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985; 5: 385–93.
61. Markus BH, Dickson ER, Grambsch PM, et al. Efficacy of liver transplantation in patients with primary cirrhosis. N Engl J Med 1989; 320: 1709–13.
62. Neuberger J, Altman DG, Christensen E, Tygstrup N, Williams R. Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation 1986; 41: 713–6.
63. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10: 1–7.
64. Fung J, Makowka L, Tzakis A, et al. Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc 1987; 20: Suppl 1: 88–91.
65. Miller C, Mazzaferro V, Makowka L, et al. Orthotopic liver transplantation for massive hepatic lymphangiomatosis. Surgery 1988; 103: 490–5.
66. Calne R, ed. Liver transplantation: the Cambridge/King's College Hospital experience. Orlando, Fla.: Grune & Stratton, 1987:3–540.
67. Shaw BW Jr, Iwatsuki S, Starzl TE. Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet 1984; 159: 490–3.
68. Shaw BW Jr, Iwatsuki S, Bron K, Starzl TE. Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet 1985; 161: 66–8.
69. Todo S, Makowka L, Tzakis AG, et al. Hepatic artery in liver transplantation. Transplant Proc 1987: 19:2406–11.
70. Shaw BW Jr, Martin DJ, Marquez JM, et al. Venous bypass in clinical liver transplantation. Ann Surg 1984; 200: 524–34.
71. Wall WJ, Grant DR, Duff JH, Kutt JL, Ghent CN, Bloch MS. Liver transplantation without venous bypass. Transplantation 1987; 43: 56–61.
72. Iwatsuki S, Shaw BW Jr, Starzl TE. Biliary tract complications in liver transplantation under cyclosporin-steroid therapy. Transplant Proc 1983; 15: 1288–91.
73. Lerut J, Gordon RD, Iwatsuki S, et al. Biliary tract complications in human orthotopic liver transplantation. Transplantation 1987; 43: 47–51.
74. Ringe B, Oldhafer K, Bunzendahl H, Bechstein WO, Pichlmayr R. Analysis of biliary complications following orthotopic liver transplantation. Transplant Proc 1989; 21: 2472–6.
75. Calne RY. A new technique for biliary drainage in orthotopic liver transplantation utilizing the gall bladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg 1976; 184: 605–9.
76. Halff G, Todo S, Hall R, Starzl TE. Late complications with the gall-bladder conduit biliary reconstruction after transplantation. Transplantation 1989; 48: 537.
77. Bismuth H, Houssin D. Reduced-size orthotopic liver graft in hepatic transplantation in children. Surgery 1984; 95: 367–70.
78. Ringe B, Pichlmayr R, Burdelski M. A new technique of hepatic vein reconstruction in partial liver transplantation. Transplant Int 1988; 1: 30–5.
79. Broelsch CE, Emond JC, Thistlethwaite JR, et al. Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg 1988; 208: 410–20.
80. Shaw BW Jr, Gordon RD, Iwatsuki S, Starzl TE. Hepatic retransplantation. Transplant Proc 1985; 17: 264–71.
81. Portmann B, Wight DGD. Pathology of liver transplantation, excluding rejection. In: Calne RY, ed. Liver transplantation: the Cambridge/King's College Hospital experience. 2nd ed. Orlando, Fla.: Grune & Stratton, 1987:438–40.
82. Todo S, Demetris AJ, Makowka L, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903–5.
83. Tzakis AG, Gordon RD, Shaw BW Jr, Iwatsuki S, Starzl TE. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation 1985; 40: 667–71.
84. Mazzaferro V, Esquivel CO, Makowka L, et al. Hepatic artery thrombosis after pediatric liver transplantation: Medical or surgical event? Transplantation 1989; 47: 971–7.
85. Klintmalm GBG, Olson LM, Paulsen AW, Whitten CW, Husberg BS. Hepatic arterial thrombosis after liver transplantation: intraoperative electromagnetic blood flow evaluation. Transplant Proc 1988; 20: Suppl 1: 616–8.
86. Groth CG. Changes in coagulation. In: Starzl TE, ed. Experience in hepatic transplantation. Philadelphia: W.B. Saunders, 1969:159–75.
87. Tisone G, Gunson BK, Buckels JA, McMaster P. Raised hematocrit — a contributing factor to hepatic artery thrombosis following liver transplantation. Transplantation 1988; 46: 162–3.
88. Harper PL, Edgar PF, Luddington RJ, et al. Protein C deficiency and portal thrombosis in liver transplantation in children. Lancet 1988; 2: 924–7.
89. McKeown CM, Edwards V, Phillips MJ, Harvey PR, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 1988; 46: 178–91.
90. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest 1986; 55: 455–62.
91. Groth CG, Porter KA, Otte JB, et al. Studies of blood flow and ultrastractural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery 1968; 63: 658–68.
92. Samuel D, Gillet D, Castaing D, Reynes M, Bismuth H. Portal and arterial thrombosis in liver transplantation: a frequent event in severe rejection. Transplant Proc 1989; 21: 2225–7.
93. Hesselink EJ, Klompmaker IJ, Pruim J, van Schilfgaarde R, Slooff MJ. Hepatic artery thrombosis after orthotopic liver transplantation — a fatal complication or an asymptomatic event. Transplant Proc 1989; 21: 2462.
94. Segel MC, Zajko AB, Bowen A, et al. Doppler ultrasound as a screen for hepatic artery thrombosis after liver transplantation. Transplantation 1986; 41: 539–41.
95. Wozney P, Zajko AB, Bron KM, Point S, Starzl TE. Vascular complications after liver transplantation: a 5-year experience. AJR 1986; 147: 657–63.
96. Zajko AB, Campbell WL, Logsdon GA, et al. Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR 1987; 149: 485–9.
97. Marino IR, Esquivel CO, Zajko AB, et al. Distal splenorenal shunt for portal vein thrombosis after liver transplantation. Am J Gastroenterol 1989; 84: 67–70.
98. Rouch DA, Emond JC, Ferrari M, Yousefzadeh D, Whitington P, Broelsch CE. The successful management of portal vein thrombosis after hepatic transplantation with a splenorenal shunt. Surg Gynecol Obstet 1988; 166: 311–6.
99. Todo S, Podesta L, Ueda Y, et al. A comparison of UW with other solutions for liver preservation in dogs. Clin Transplant 1989; 3: 253–9.
100. Lanir A, Jenkins RL, Caldwell C, Lee RG, Khettry U, Clouse ME. Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology 1988; 8: 471–5.
101. Kamiike W, Burdelski M, Steinhoff G, Ringe B, Lauchart W, Pichlmayr R. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 1988; 45: 138–43.
102. Fath JJ, Ascher NL, Konstantinides FN, et al. Metabolism during hepatic transplantation: indications of allograft function. Surgery 1984; 96: 664–74.
103. Jenkins RL, Clowes GH Jr, Bosari S, Pearl RH, Khettry U, Trey C. Survival from hepatic transplantation: relationship of protein synthesis to histological abnormalities in patient selection and postoperative management. Ann Surg 1986; 204: 364–74.
104. Starzl TE, Tzakis A, Makowka L, et al. The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc 1987; 19: 4492–7.
105. Gordon RD, Fung JJ, Markus B, et al. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705–15.
106. Gordon RD, Iwatsuki S, Esquivel CO, Tzakis A, Todo S, Starzl TE. Liver transplantation across ABO blood groups. Surgery 1986; 100: 342–8.
107. Gugenheim J, Samuel D, Fabiani B, et al. Rejection of ABO incompatible liver allografts in man. Transplant Proc 1989; 21: 2223–4.
108. Demetris AJ, Jaffe R, Tzakis A, et al. Antibody-mediated rejection of human orthotopic liver allografts: a study of liver transplantation across ABO blood group barriers. Am J Pathol 1988; 132: 489–502.
109. Rego J, Prevost F, Rumeau JL, et al. Hyperacute rejection after ABO-incompatible orthotopic liver transplantation. Transplant Proc 1987; 19: 4589–90.
110. Terasaki PI, Bemoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. Am J Clin Pathol 1978; 69: 103–20.
111. Starzl TE, Lerner RA, Dixon FJ, Groth CG, Brettschneider L, Terasaki PI. Shwartzman reaction after human renal homotransplantation. N Engl J Med 1968; 278: 642–8.
112. Starzl TE, Boehmig HJ, Amemiya H, et al. Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med 1970; 283: 383–90.
113. Hume DM, Williams GM. Personal communication, February 8, 1969. In: Starzl TE, ed. Experience in hepatic transplantation. Philadelphia: W.B. Saunders, 1969:269.
114. Knechtle SJ, Kolbeck PC, Tsuchimoto S, Coundouriotis A, Sanfilippo F, Bollinger RR. Hepatic transplantation into sensitized recipients: demonstration of hyperacute rejection. Transplantation 1987; 43: 8–12.
115. Gubernatis G, Lauchart W, Jonker M, et al. Signs of hyperacute rejection of liver grafts in Rhesus monkeys after donor-specific presensitization. Transplant Proc 1987; 19: 1082–3.
116. Houssin D, Gugenheim J, Bellon B, et al. Absence of hyperacute rejection of liver allografts in hypersensitized rats. Transplant Proc 1985; 17: 293–5.
117. Starzl TE, Demetris AJ, Todo S, et al. Evidence for hyperacute rejection of human liver grafts: the case of the canary kidneys. Clin Transplant 1989; 3: 37–48.
118. Bird G, Friend P, Donaldson P, et al. Hyperacute rejection in liver transplantation: a case report. Transplant Proc 1989; 21: 3742–4.
119. Hanto DW, Snover DC, Sibley RK, et al. Hyperacute rejection of a human orthotopic liver allograft in a presensitized recipient. Clin Transplant 1987; 1: 304–10.